NHS England has published further guidance for pharmacy contractors taking part in the quality payments scheme. This should be read in conjunction with the two previously published guidance documents. The guidance clarifies the requirements for meeting the gateway and quality criteria, completing the November declaration process and providing evidence for the validation procedures.
Changes are being made to the list of elective surgeries covered by patient reported outcome measures, the “before and after” research to measure how much patients feel they have benefited from their operation. PROMs for groin hernia and varicose vein operations are being phased out from 1 October 2017, but measures for hips and knee procedures will remain.
A number of high cost drugs and devices are paid for over and above the national tariff price for the related service. These drugs and devices appear on a high cost list which is part of the national tariff for 2017 to 2019. NHS England has opened a high cost drugs and devices survey for anyone to nominate drugs and devices to be added to, or removed from, the high cost lists for the next national tariff, due to take effect in April 2019. The closing date for nominations is 17 November 2017.
NHS England has published the findings of a campaign to develop better IT for personalised care, as part of work to develop the IT supplier market for personal health budgets. The scheme drew applications from more than 20 IT suppliers and resulted in six actions for commissioners to support the development of more effective IT systems. For more information about IT for personalised care, please email England.PersonalisationIT@nhs.net.
NHS England has reminded CCGs of items that should not be prescribed in primary care, as part of a drive to reduce unnecessary costs. A consultation on items considered a low priority for funding closes on 21 October. NHS England is urging CCGs to engage with their local communities on the proposals and to respond to the consultation.